SKYRIZI Sol inj 150 mg/ml Ser prér, 1pce

7680669440022 CH-66944 L04AC18 07.15.0.

Active substances:

SKYRIZI Sol inj 150 mg/ml Ser prér, 1pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6694402
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
risankizumabum 150 mg, natrii acetas trihydricus corresp. natrium 0.209 mg, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Skyrizi 150 mg, lnjektionslösung in einer Fertigspritze
Fertigspritze
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
08/02/2026
Professional SmPC
Français
08/02/2026
Professional SmPC
Italien
08/02/2026

Detailed composition

Substance Quantity Type Category
risankizumabum
150.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.209 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 3146.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2021

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
66944
Drug name
Skyrizi, lnjektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AC18
Authorization status
Z
Dispensation category
B
First authorization
18/04/2019
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis bei Erwachsenen, Psoriasis-Arthritis

Packaging details

Description (FR)
SKYRIZI Sol inj 150 mg/ml Ser prér, 1pce
Description (DE)
SKYRIZI Inj Lös 150 mg/ml Fertspr, 1Stk
Market launch
07/07/2021
Narcotic (BTM)
No

Other packaging sizes

SKYRIZI Sol inj 75 mg/0.83ml Ser prér, 2pce
2 FESP
View
Buy us a coffee Explore the data